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Abstract.  The ability of the chick embryo chorioal- 
lantoic membrane (CAM) to withstand invasion by 
tumor ceils can be intentionally compromised by 
altering its morphological integrity. Using a  newly de- 
veloped quantitative assay of invasion we showed that 
intact CAMs were completely resistant to invasion by 
tumor cells, wounded CAMs did not pose a barrier to 
penetration, and CAMs that were wounded and then 
allowed to reseal displayed partial susceptibility to in- 
vasion. The invasion of resealed CAMs required cata- 
lytically active plasminogen activator (PA)  of the uro- 
kinase type (uPA); the invasive efficiency of tumor 
cells was reduced by 75%  when tumor uPA activity 
or tumor uPA production was inhibited. The invasive 
ability of human tumor cells, which have surface uPA 
receptors but which do not produce the enzyme, could 
be augmented by saturating their receptors with exoge- 
nous uPA. The mere stimulation of either uPA or tis- 
sue plasminogen activator production, in absence of 
binding to cell receptors, did not result in an enhance- 
ment of invasiveness. 
These findings suggest that the increased invasive 
potential of tumor cells is correlated with cell sur- 
face-associated proteolytic activity stemming from the 
interaction between uPA and its surface receptor. 
OCAL infiltration of normal tissue by tumor cells and 
their dissemination to distant sites involve migration 
through the stroma of connective tissue as well as the 
penetration  of natural  barriers,  such  as  basement  mem- 
branes. The invasiveness of tumor cells has been studied in 
a variety of experimental models (Albini et al., 1987; Foltz 
et al., 1982; Jones et al., 1981; Mignatti et al., 1986; Starkey 
et al., 1984; Terranova et al., 1986), including the chorioal- 
lantoic membrane (CAM) ~ (Armstrong et al.,  1982; Leigh- 
ton,  1964;  Ossowski and Reich,  1983;  Poste et al.,  1980; 
Poste  and Flood,  1979;  Scher et al.,  1976). It has been 
shown in a number of  these models that tumor cells elaborate 
enzymes that can degrade components of the extracellular 
matrix (Dane et al., 1985; Jones et al., 1981; Mignatti et al., 
1986;  Nakajima et al.,  1984;  Salo et al.,  1982;  Sas et al., 
1986;  Sloane  et  al.,  1986).  In  most  cases  enhanced 
metastatic potential of cells was shown to be correlated with 
their greater ability to degrade matrix components (Dane et 
al., 1985; Jones et al., 1981; Liotta et al., 1980; Salo et al., 
1982; Sloane et al., 1986; Terranova et al., 1986) but some 
lack of correlation has also been observed (Sas et al., 1986). 
It is conceivable that the above discrepancies were due to an 
inability to mimic in vitro the highly specialized interactions 
that occur in vivo between tumor cells and the complex and 
heterogenous extracellular components. 
1. Abbreviations used in this paper: CAM, chorioallantoic membrane; EGF, 
epidermal growth factor; HMW-uPA, high molecular weight urokinase-type 
plasminogen activator;  PA, plasminogen activator;  tPA, tissue-type plas- 
minogen activator;  uPA, urokinase-type  plasminogen activator. 
The CAM model, which combines the technical simplicity 
of an in vitro assay with the advantages of an in vivo environ- 
ment, has been used in the past by a number of investigators 
to study the invasiveness of viraUy transformed cells or tu- 
mor cell lines, however,  the role of preteolytic enzymes in 
invasion has not been studied in this model. The results of 
these studies have been conflicting probably because, with 
few exceptions (Armstrong et al., 1982), the morphological 
integrity of CAMs used for inoculations was not carefully as- 
sessed. Indeed, histological assessment of CAMs in the pres- 
ent study revealed that the method  "used for their preparation 
had a pronounced effect on their morphology. The suscepti- 
bility of these CAMs to tumor cell invasion was correlated 
with their structural integrity. This observation was used in 
preparation  of CAMs  that were  completely,  partially,  or 
minimally resistant to tumor cell invasion. 
The use of partially resistant CAMs permitted the exami- 
nation of the role of plasminogen activator (PA) content, PA 
type (urokinase-type PA [uPA] vs. tissue-type PA [tPA]), and 
PA localization (soluble in the medium vs. surface receptor 
bound) in invasion of CAMs by tumor cells. Plasma mem- 
brane receptors for uPA have been recently identified on a 
number of cells (Vassalli et al., 1985), including tumor cells 
(Stoppelli et al., 1986). uPA binds to these receptors via the 
amino-terminal portion of the molecule and remains catalyti- 
cally active (Appella et al., 1987; Stoppelli et al., 1986; Vas- 
salli et al., 1985). In most uPA-producing cells the receptors 
are fully occupied by the endogenously produced enzyme 
(Stoppelli et al., 1986) but, as will be shown, in some cells 
the receptor is synthesized in the absence of uPA production. 
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which remains active on the surface of the cells, allowed the 
testing of its role in enhancing tumor cell invasion. Also, 
since human receptors only bind human uPA (Appella et al., 
1987; Huarte et al.,  1987) we were able, by using human 
cells expressing very high levels of muse uPA, to determine 
whether overproduction of uPA, which because of its origin 
cannot bind to human uPA receptors,  will equip the cells 
with an increased invasive potential. 
Materials and Methods 
Materials 
COFAL-negative embryonated eggs were obtained from Spafas, Inc. (Nor- 
wich, CT); DME from Gibco Laboratories (Grand Island, NY); FBS from 
Hazleton Research Products Inc. (Lenexa, KS);  '25IUdR (specific activity 
of 2,200 Ci/mmol) from New England Nuclear (Boston, MA); human uro- 
kinase standard from Leo Pharmaceuticals (Ballerup, Denmark), Breoki- 
nase (high molecular weight urokinase) from Green Cross Corp. (supplied 
by Breon Lab. Inc., NY), Abbokinase (low molecular weight urokinase) 
from Abbott Laboratories (North Chicago, IL); Triton X-100, coUagenase 
type 1A, and DMSO from Sigma Chemical Co. (St. Louis, MO); chromo- 
genie substrate for plasmin (Spectrozyme PL) from American Diagnostica 
Inc. (New York, NY). Human plasminogen was purified from fresh human 
plasma as previously described (Deutsch and Mertz, 1970); bovine fibrino- 
gen (Calbiochem-Behring Corp., La Jolla, CA) and rabbit anti-human uPA 
were prepared as described (Strickland and Beers,  1976;  Ossowski and 
Reich, 1983);  rabbit anti-mouse uPA IgG was purified from serum of rab- 
bits immunized with PA purified from conditioned medium of Lewis lung 
carcinoma cells. 
Cell Lines 
HEp3 cells (Toolan,  1954)  were obtained by collagenase dissociation of 
HEp3 tumors, serially passaged on CAMs of 10-d-old chick embryos, using 
previously described techniques (Ossowski and Reich,  1980).  HeLa cells 
maintained in our laboratory were originally obtained from Dr.  J. Nevins 
(Rockefeller University), and Wish-mUK, a  human cell line transfected 
with mouse uPA cDNA (Belin et al., 1985), under the transcrptional control 
of a  human  heat  shock  promoter using  a  previously described vector 
(Dreano et al., 1987),  was generously donated by Dr. D. Belin (University 
of Geneva Medical School, Switzerland). 
Methods 
Quantitation of Tumor Cells in CAM Mesenchyme. HEp3 cells, prepared 
by dissociation of serially passaged CAM-HEp3 tumors (Ossowski and 
Reich, 1980),  were grown in culture for 2-4 d and labeled with 0.2 gCi/ml 
of 125IUdR for 24-48 h. Specific activity of these cells varied from 0.1 to 
0.3 cpm/cell. CAMs of 10-d-old embryos, separated from the egg shell by 
creation of an artificial air chamber (Ossowski and Reich, 1980), were inoc- 
ulated with 4  x  105 cells per CAM, incubated for 8 h at 3"/°C, washed in 
situ five times with PBS (I mi per wash) and excised. Extreme care was 
taken not to damage the CAMs during this procedure. The CAMs were in- 
cubated for 20 min in 35-mm culture dishes with 2 ml of TD buffer (1 liter 
of TD buffer contains 16 g  NaCI, 0.76 g KCI, 0.2 g  Na2HPO4  ×  7 1-120 
and 6 g Sigma 7-9; Sigma Chemical Co.) and trypsin-EDTA (0.05% trypsin, 
1 mM EDTA) or in 2 ml of PBS (1 liter of PBS contains 8 g NaCI, 0.2 g 
KCI, 0.2 g KH2PO4, 2.16  g Na2HPO4  x  7 H20) with 0.15%  collagenase 
and 2.5 % BSA. At the end of incubation the CAMs were carefully removed 
from the enzyme solutions, rinsed gently in 2 ml of PBS, and counted in 
a gamma counter. All the PBS washes were centrifuged at low speed and 
the supernatants and pellets were als0 counted in the gamma counter. Rou- 
tinely, >95% of the radioactivity was found in the pellets. To ensure that 
the incorporated ~25IUdR was not released and reused by the surrounding 
normal cells, CAMs inoculated with radioactive cells were dissociated with 
collagenase into single cell suspensions 20 and 40 h after inoculation. The 
specific radioactivity of the tumor cells, which are very large and easily 
distinguishable from the chick cells, was determined. After correction for 
the increase in tumor cell number during these periods the specific radioac- 
tivity was found to be unchanged. 
Preparation of CAMs. Intact CAMs were prepared as described (Scher 
et al., 1976). Briefly, 2 ml of albumin was removed from 5-d-old embryos, 
before the development  of  the CAM. The eggs were incubated on their sides 
in a stationary incubator. This procedure resulted in the creation of a space 
between the egg shell and the rest of the egg content and allowed forthe 
development of the CAM unattached to the egg shell membrane. Wounded 
CAMs were prepared in 10-d-old embryos by puncturing the egg shell on 
the long side of the egg and applying negative pressure through an opening 
in the egg shell over the natural air sac. This procedure, which led to the 
formation of a new air sac by mechanical separation of the CAM from the 
egg shell  membrane, resulted in severe damage to the CAM.  Resealed 
CAMs were prepared by the above procedure except that wounding was fol- 
lowed by incubation of eggs, before inoculation, for periods varying from 
7 to 30 h. Histological examinations were done on sections obtained from 
tissues fixed in buffered formalin, embedded in paraffin, and stained with 
hematoxylin and eosin. 
Plasminogen Activator Determinations. All methods used have been 
described previously (Ossowski and Reich,  1980;  Strickland and Beers, 
1976).  We found that the radioactive fibrin plate method (Stricldand and 
Beers, 1976) and the assay which used chromogenic substrate for plasmin 
(Spectrozyme PL;  American  Diagnostiea  Inc.)  (Mira-y-Lopez and  Os- 
sowski, 1987; Verheijen et al., 1982), gave comparable results. Both assays 
detected as little as 0.5-1 mU of uPA. 
Detection of uPA Receptors and Determination of Receptor-bound 
uPA Activity. HeLa, HEp3, and Wish-mUK cells were plated at 2  ×  105 
in 24-well tissue culture trays and incubated with iodinated high molecular 
weigh uPA (HMW-uPA) as previously described (Vassalli et al., 1985; Stop- 
pelli et al., 1986). 20-fold excess of unlabeled HMW-uPA (catalytically ac- 
tive or inactivated by incubation with 20 mM DFP for 60 min at 37°C, fol- 
lowed by extensive dialysis) was used to determine the nonspecific binding. 
Low molecular weight uPA could neither bind to the receptor nor could it 
compete, even at a  100-fold  molar excess, for the binding of HMW-uPA. 
The stripping of occupied receptors was performed as previously described 
(Stoppelli et al., 1986). To determine the functional stability of  the receptor- 
bound uPA, HeLa cells were plated at 2  ×  10  ~ per well in a 96-well tray 
and the following day all the cultures were washed twice with PBS-BSA. 
Half of the cultures were incubated in PBS-BSA with 0.1 gg/ml of HMW- 
uPA and the other half, incubated in PBS-BSA alone, served as controls. 
At different times, eight wells in each group were washed four times with 
PBS-BSA. Four wells in each group were incubated for 30 min at 37°C with 
50 ~tl of PBS-BSA containing 1 mg/ml of human plasminogen, the other 
four served as background controls (incubated in PBS-BSA alone). The su- 
pernatants of all cultures were aspirated, centrifuged, and their plasmin ac- 
tivity was determined. 
Preparation of HeLa Cells with Receptor-bound uPA. Cells  (2  × 
106/ml) detached with Tris-saline-1 mM EDTA (pH 7.4) were resuspended 
in Dulbecco's medium with 20 mM Hepes and 1 mg/ml BSA (DB-Hepes- 
BSA) and incubated for 45 min at 4°C with 0, 0.1, 0.2, or 0.4 gg/rnl of 
HMW-uPA (HeLa cells) and with 0.2 gg/ml (Wish-mUK and HEp3 cells). 
After three washes with DB-Hepes-BSA the cells were resuspended in PBS 
containing 1 mg/ml of human plasminogen, dispensed (I00 lxl) into plastic 
tubes at 2  x  105 per tube, and incubated for 30 min at 37"C. The superna- 
tants were separated by centrifugation and assayed for plasmin activity by 
fibrin plate or chromogenic assays. As a control, supernatants of cells that 
had been incubated without plasminogen were mixed with 1 mg/ml of plas- 
minogen, incubated under identical conditions as the experimental, and as- 
sayed for plasmin activity.  Only the supernatant from HeLa cells, prein- 
cubated with 0.4 Ixg/ml of uPA, had a small but detectable plasmin activity 
when subsequently mixed with plasminogen; this activity was subtracted 
from the experimental value. 
IdenU'fication of  PA 1~pes  Produced by Cells. Two methods were used 
to determine whether the PA produced was of the tPA or the uPA type, and 
whether it was of mouse or human origin. Lysates and conditioned media 
of cells were subjected to electrophoresis on SDS-PAGE and simultaneous 
determinations of molecular weight and activity were performed using 
zymography (Granelli-Piperno and Reich, 1978).  In addition, cell lysates 
and conditioned media were preincubated with specific, inhibitory antibod- 
ies and the residual PA activity of these mixtures was measured using fibrin 
plate or chromogenic substrate assays. 
Results 
Quantitation of Tumor Cells in the CAM Mesenchyme 
To quantitate the efficiency of penetration of CAMs by tumor 
cells, chick embryos were inoculated on CAMs with labeled 
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Figure 1. Quantitation of tumor cells inside the CAM mesenchyme. 
Two CAMs were inoculated with 2  x  105 ~25IUdR-labeled HEp3 
cells (0.23 cpm/cell) and, after 8 h of incubation, the CAMs were 
washed in situ five times with 1 ml of PBS. Care was taken not to 
damage the CAMs during washing. The CAMs were excised and 
incubated at 37°C in 2 ml of 0.05% trypsin and 1 mM EDTA. At 
indicated times, the CAMs were removed, counted in a gamma 
counter, and reincubated in fresh enzyme solutions. The results 
shown are the average of two CAMs and are expressed as percent 
of total radioactivity recovered in washes, released by trypsin, and 
found associated with the CAMs. The total recovered radioactivity 
was 80% of inoculum. (Solid circles) Radioactive cells released in 
PBS washes; (open circles) radioactive cells released by trypsin- 
EDTA treatment. 
tumor cells.  At the end of 8 h of incubation the CAMs were 
subjected  to  repeated  washing  with  PBS  which  removed 
nearly half of the total radioactive tumor cells. Subsequently, 
the washed CAMs were excised and incubated in trypsin- 
EDTA solution; an additional 25% of all cells was released 
in the first 20 min of  this treatment, the rest of  the radioactive 
cells (30% of the total number of recovered cells) was com- 
pletely resistant to further treatment with the enzyme (Fig. 
1), and remained associated with the CAMs even after 1 h 
of incubation  (not  shown).  CAMs of embryos inoculated 
with tumor cells and incubated for periods of  up to 72 h, con- 
tained  greater proportions (up  to 80%)  of cells  protected 
from the action of trypsin. To identify the trypsin-protected 
compartment by histology, CAMs incubated for 40 h after in- 
oculation with tumor cells were excised and sectioned before 
and after trypsin-EDTA treatment (Fig. 2). The comparison 
of  these sections showed that the enzyme treatment primarily 
released tumor cells attached to the outer surface of  the CAM 
(Fig.  2),  leaving the cells which had penetrated the CAM 
mesenchyme in place. These cells could only be released by 
enzymes, such as collagenase, which caused a complete dis- 
integration of the CAM structure (not shown).  Similar re- 
suits  were seen with CAMs examined 8 h after inoculation 
but, in this case, the number of tumor cells in the CAM mes- 
enchyme was too small for efficient visualization in histologi- 
cal sections. 
Effect of  Structural Integrity of CAMs on the 
Susceptibility to Invasion by Tumor Cells 
Different experimental procedures used to prepare CAMs for 
Figure 2. The effect of trypsin-EDTA treatment on the CAM surface-attached HEp3 cells. CAMs were inoculated with 5  x  10  ~ HEp3 
cells, incubated for 40 h, washed in situ with PBS, and excised. The CAM shown in A was immediately fixed. The CAM shown in B 
was incubated for 20 min with trypsin-EDTA, rinsed gently with PBS, and then fixed. Both CAMs were sectioned and stained with H&E. 
Arrows indicate tumor cells. 
Ossowski Surface-bound Urokinase and Tumor Cell  Invasion  2439 Figure 3. Morphology of intact, wounded, and resealed CAMs. (A) Intact CAM from a 10-d-old embryo, prepared as described in Materials 
and Methods, was excised, folded to fit more surface area into a single histological section, and fixed. The photomicrograph shows a section 
through CAM in which, due to folding, two chorionic epithelia face each other. Note the continuity of the epithelium and the richness 
of the vasculature immediately adjacent to the epithelium. (B and C) Wounded CAMs were excised from 10-d-old embryos (see Materials 
and Methods),  fixed immediately, and used for preparation of histological sections. Note that this method of CAM preparation  resulted 
in some areas in the disappearance of the entire chorionic epithelium from the surface of the CAM (B), and that extensive bleeding was 
evident in other areas of the CAM (C). (D and E) Resealed CAMs were prepared by incubating embryos with wounded CAMs for 30 h, 
followed by excision and fixation of the CAMs. Note that the fibroblasts in the mesenchyme are aligned perpendicularly  to the surface, 
but that on the surface they form an almost continuous multilayered (D) or double-layered (E) sheet. CE, chorionic epithelium; BV, blood 
vessel; RBC, red blood cells; AE, allantoic epithelium. 
tumor cell inoculation yielded CAMs with a variable degree 
of epithelial  injury.  We  examined  the  morphology of the 
CAMs prepared by three methods and compared their sensi- 
tivity to tumor cell invasion. We found that in an intact CAM 
(see Materials and Methods for preparation) the chorionic 
epithelium, which is known to be composed of one to four 
layers of cells resting on a basement membrane, remained in 
its original state (Fig. 3 A); a large number of capillary blood 
vessels was present in the mesenchyme immediately under- 
lying the  epithelium.  In contrast,  in  the  wounded  CAMs, 
prepared by a routinely used method of an artificial air sac 
formation, the chorionic epithelium was completely missing 
in many areas of the CAM (Fig. 3 B), and extensive hemor- 
rhage was often observed immediately after wounding (Fig. 
3  C). Incubation of embryos with wounded CAMs at 37°C 
led to formation of continuous, single, or multilayered sheets 
of cells on the wounded surfaces (resealed CAM; Fig. 3, D 
and E). Examination of sections of CAMs prepared at 8-12 
h after wounding revealed the presence in the mesenchyme 
of fibroblast-like cells, positioned vertically, with their long 
axes perpendicular to the wounded surface (not shown). Ap- 
proximately 30 h after wounding the CAM surface was re- 
sealed with a  continuous layer of fibroblast-like ceils (Fig. 
3, D and E). Lateral migration from the edge of the wounded 
chorionic epithelium was not seen in any of the examined 
sections. 
Intact, wounded, and resealed CAMs were inoculated with 
radioactive HEp3  cells and,  after 20  h  of incubation,  the 
number of tumor cells that had laenetrated the mesenchyme 
was quantitated using the trypsin-EDTA incubation.  In the 
wounded CAMs, 50% and in the CAMs resealed for 7 h 40% 
of the inoculum was found in the mesenchyme. In contrast, 
only 23 %  of the  inoculated  tumor cells was  found in the 
mesenchyme of CAMs wounded and resealed for 28 h. Intact 
CAMs were completely resistant to invasion by HEp3 cells 
(Fig.  4). 
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Figure 4. Correlation between 
the structural  integrity of the 
CAM and its susceptibility to 
invasion by tumor cells.  Ra- 
dioactive  HEp3  cells  (0.27 
cpm/cell,  2  x  1@  cells  per 
CAM) were inoculated on six 
of each of the following: intact, 
wounded, and resealed CAMs. 
The  latter  were  allowed  to 
reseal for either 7 or 28 h be- 
fore  inoculation  with  tumor 
cells.  After  22  h  of incuba- 
tion, all CAMs were washed, 
excised, treated with trypsin- 
EDTA for 20 min, and counted 
in a gamma counter. The mean 
number of tumor cells in the 
mesenchyme  of the  different 
CAMs was compared to that of wounded CAMs by Student t test. 
The number of cells in the CAM resealed for 7 h did not differ 
significantly from the wounded CAM; the intact CAM and CAM 
resealed for 28 h were significantly different (P < 0.01). The vertical 
bars indicate standard deviations. 
Involvement of  PAs in CAM Invasion 
The role of uPA in CAM invasion was examined by compar- 
ing the invasive ability of HEp3 cells expressing high levels 
of uPA activity to HEp3 cells in which uPA activity was in- 
hibited by anti-uPA IgG (Ossowski and Reich,  1983), or in 
which  enzyme production  was  blocked  by  preincubation 
with  1.3%  DMSO  (Ossowski and Belin,  1985;  Ossowski, 
1988),  a  treatment that reduced the HEp3-uPA activity by 
>90%. 
Wounded or resealed CAMs were inoculated with control, 
anti-uPA IgG-treated or DMSO-treated HEp3 cells, and the 
number of tumor cells in CAM mesenchyme was determined 
Table I. The Effect of  Inhibition of  uPA Activity 
or Synthesis on HEp3 Cell Invasion of Wounded 
or Resealed CAMS 
Time between  Radioactivity in CAM (percent  of inoculum) 
CAM preparation 
and inoculation  Control  DMSO-treated  Anti-uPA IgG 
of cells  mean (SD)  mean (SD)  mean (SD) 
h 
0  43  (+  ll)  37  (:t:  5)  35  (-i-  12) 
8  45  (-t-  7)  34  (+  14)*  ND 
30  22  (+  11)  6  (+  3)~  5  (+  3)$ 
HEp3  cells, obtained by dissociation of HEp3  tumor transplanted serially on 
CAMs, were plated at 1.5  ×  106 per 100-mm dish in medium with 10%  se- 
rum. The next day, serum concentration  was lowered to 5 % and one group of 
cultures received  1.3%  DMSO.  The  next day  ~2SlUdR (0.2  mCi/ml) was 
added and cultures were incubated for another 24 h. Control cells incorporated 
0.3 el>m/cell and DMSO cells 0.24 cpm/cell. Control or DMSO treated, radio- 
active cells (4  x  105 per CAM) were inoculated on wounded  CAMs or on 
CAMs resealed for 8 or 30 h.  12 eggs were used for each experimental group. 
Also, an aliquot of the control cells was resuspended in rabbit anti-uPA IgG 
(1.5  mg/50 Itl) and inoculated on either wounded or resealed CAMs which 
received 1.5 mg/CAM of the same IgG 1 h before  inoculation.  The embryos 
were incubated for 20 h, at which time the CAMs were excised and the number 
of tumor ceils in the CAM  mesenchyme was determined.  Student  t test was 
used to compare the invasion by control and anti-uPA and control and DMSO- 
treated cells. 
*, P <  0.05. 
~, P<  0.005. 
20 h later. The inhibition of uPA activity or production only 
slightly  reduced  the  number of tumor  cells  found  in  the 
mesenchyme of CAMs which were susceptible to invasion, 
i.e., wounded CAMs and CAMs resealed for 8 h  (Table I). 
However, in CAMs resealed for 30 h, which, as shown above 
(Fig. 4), were more resistant to penetration by tumor cells, 
the  inhibition  of tumor cell uPA reduced  the cell number 
found in the CAM mesenchyme by ~75 %  (Table I). 
Can Invasiveness Be Enhanced by 
Stimulation of tPA Production? 
HeLa cells, which endogenously produce only low levels of 
tPA, were preincubated with epidermal growth factor, a treat- 
ment which resulted in a 39-fold increase in the tPA activity 
released by the cells over a 24-h period (Table II); the cell- 
associated activity rose only 4-fold (Table II). This enhanced 
production was maintained for at least 24 h after the removal 
of the growth factor from the incubation medium (Table II) 
indicating  that,  once the  production  was  initiated,  it pro- 
ceeded in the absence of an exogenous stimulus.  Both the 
released and the cell-associated activity were completely in- 
hibited by anti-tPA IgG (not shown). As is evident from Fig. 
5, the ability to produce greatly enhanced levels of tPA did 
not  increase  the  efficiency of penetration  of wounded  or 
resealed CAMs. 
Is Binding of  uPA to Cell Surface Receptors a 
Prerequisite for uPA Enhancement of  Invasion? 
To test whether stimulation of production and release of uPA 
is sufficient to enhance tumor cell invasiveness, we used a 
human cell line (Wish) transfected with a mouse uPA-cDNA 
under the transcriptional control of a human heat shock pro- 
moter. Wish-mUK cells were induced to synthesize mouse 
uPA by 2 h of exposure to 43°C. As seen in Fig. 6, between 
6 and 24 h after the heat shock, PA production in these cells 
rose from undetectable levels to almost 1,000 mU/106 cells. 
Most of the PA activity was found in the conditioned medium 
(Fig.  6).  The mouse origin of the cell associated and the 
secreted  PAs  was  ascertained  by  zymography  (Granelli- 
Piperno and Reich,  1978)  and by inhibition of activity with 
specific rabbit anti-mouse uPA IgG (not shown). It has been 
previously established that the binding of uPA to its receptor 
Table II. Stimulation of  tPA Production in 
HeLa Cells by EGF 
EGF  tPA 
Day  1  Day 2  Cell associated  In conditioned medium 
ng/ml  ng/ml  mU/2  ×105 cells  mU/2  xlO  5 cells 
0  0  17.0  44.0 
2  2  67.0  1699.0 
2  0  47.0  2709.0 
HeLa cells were plated at 1 x  105 per 35-mm dish in medium with 5%  FBS. 
On day 1, four cultures received 2 ng/ml of EGF and two served as controls; 
on day 2,  all cultures were washed  and two of the cultures, preincubated  in 
EGF, were left without the growth factor; on day 3, media and cells were col- 
lected and used to determine PA activity. The numbers represent the mean PA 
in two cultures. Each PA determination was done in duplicate. The difference 
between assay duplicates was <14% and between duplicate cultures, <22%. 
The activity of cell-associated and cell-free PA was completely inhibited  by 
preincubation  with 200 ~tg/ml of rabbit anti-tPA lgG and not inhibited by 200 
~tg/ml of rabbit  anti-uPA lgG. 
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Figure 5. The lack of tPA ef- 
fect on cell invasiveness. He- 
La cells treated with 2 ng/ml 
of EGF exactly as described in 
the legend to Table II, except 
that  they  were  labeled with 
t2~IUdR to a  specific activity 
of 0.17 cpm/cell, and untreat- 
ed,  labeled Helm  cells were 
inoculated (5  x  105 cells per 
CAM) on wounded CAMs or 
CAMs  that  were  allowed to 
reseal for 30 h. After 20 h of 
incubation  the  CAMs  were 
washed, excised, treated with 
trypsin-EDTA, and counted in 
a  gamma  counter.  Each  ex- 
perimental point is the mean of 
six CAMs. The vertical lines 
show standard deviations. 
is  species restricted (Appella et al.,  1987;  Huarte  et  al., 
1987).  By  using  a  published procedure  (Stoppelli et  al., 
1986) we examined the binding kinetics of human 'z~I-labeled 
HMW-uPA to Wish-mUK cells and, from a Scatchard plot, 
calculated the receptor site number for uPA to be 100,000 per 
cell. The uPA receptors were found to be unoccupied in both 
control  cells,  which  do  not  produce  uPA,  and  in  heat 
shock-induced ceils which produce 1,000 mU per 106 cells 
1000 !  - 
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-6 0  24  48  72  96 
Time  ofter heot shock (h) 
Figure 6. Stimulation of uPA activity in human cells (Wish-mUK) 
transfected with mouse uPA DNA. Wish-mUK cells were plated in 
25-cm  2 flasks at 2.5  x  1@ cells per flask. When semiconfluent, 
they were filled with medium containing 5 % FBS and heat shocked 
by submerging in a 43°C water bath for 2 h. 6 h after exposure to 
heat, and every 24 h  thereafter, the medium and cells from two 
flasks were collected and used to determine PA activity. Medium 
was replaced in all remaining flasks. The results given are the aver- 
ages of two flasks and four PA determinations. The values did not 
differ by >7%.  All of the PA activity was  shown by zymography 
(Granelli-Piperno and  Reich,  1978) to comigrate with  standard 
mouse uPA. The activity was completely inhibited by specific, rab- 
bit anti-mouse uPA IgG. (Open circles) Cell-associated PA; (solid 
circles) PA in conditioned medium. 
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Figure 7. Invasion of CAM by 
control and mouse uPA produc- 
ing Wish-mUK cells. 125IUdR- 
labeled (0.2 cpm/cell) control 
and heat-shocked cells, used 
immediately, 6, and 24 h after 
the exposure to 43°C, were in- 
oculated onto wounded and re- 
sealed CAMs (3  x  105 cells 
per CAM). After 20 h of incu- 
bation the CAMs were excised 
and tumor cell invasion was 
quantitated  as  described  in 
Materials and Methods. 
of mouse uPA.  This  indicated that the endogenously pro- 
duced uPA did not bind to receptors present on human cells 
(results not shown). 
The  invasive  ability  of  these  cells  (controls  and  heat 
shocked,  taken immediately after exposure to 43°C  or in- 
cubated for an additional 6 or 24 h) was examined by inocula- 
tion onto wounded and resealed (30 h) CAMs. As shown in 
Fig. 7, cells stimulated to produce very high levels of mouse 
uPA, which is unable to bind to human uPA receptors, were 
not more invasive than control cells, suggesting that mem- 
brane localization of uPA may be crucial for the enhance- 
ment of invasion. 
To  test  this  possibility more  directly,  Wish-mUK  and 
HeLa cells were preincubated with uPA in vitro, a treatment 
that equipped them with surface-bound enzyme.  The num- 
ber  of uPA  receptors on  HeLa  cells was  calculated from 
Scatchard analysis to be 37,000; the dissociation constants for 
uPA on both HeLa and Wish-mUK cells were found to be in 
the subnanamolar range. In the native state the receptors in 
both types of cells were unoccupied (not shown); Wish-mUK 
cells did not produce detectable PA, while the line of HeLa 
cells  used  produced  tPA  exclusively.  Incubation  of HeLa 
cells with increasing concentrations (0.1-0.4  ltg/ml) of hu- 
man  HMW-uPA yielded cells with greatly enhanced,  sur- 
face-bound plasminogen-activating activity (Fig. 8);  HeLa 
cells exposed to 0.2 Itg/ml of uPA (a concentration 10 times 
in excess of the calculated Kd value for uPA binding) were 
most effective in activation of plasminogen to plasmin (Fig. 
8).  More than 50%  of the surface-bound enzyme remained 
active 8  h  after it was bound to the receptors (Fig. 9). 
Figure 8. PA activity of HeLa and 
-  ~o  ~  HEp3 cells incubated with uPA. 
~ __  /  -"~  HeLa and HEp3 cells (2  x  106/ 
,~  ~ z0  /  ml) were incubated in suspension 
-a "~  /  with  0,  0.1, 0.2,  or  0.4  txg/ml  F,g  J--°  io  HMW-uPA (Helm), or 0, and 0.2 
~-  ~g/ml HMW-uPA (HEp3). After 
~,=  ~  t  ~  three  washes,  aliquots  of  cells 
o.i  0.2  04  (2  x  l0  s per 100 p.l) were incu- 
uPA in preincubotion  (~.g/ml)  bated for 30 min at 37°C with or 
without 1 mg/ml of human plas- 
minogen. At the end of incubation, the cells were removed by cen- 
trifugation and the supernatants were assayed for plasmin activity 
by a fibrin plate assay (Strickland and Beers, 1976). The results are 
the average of two determinations which did not differ by >4%. 
(Open circles) HEp3 cells; (solid circles) HeLa cells. 
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Figure  9.  The  stability  of plas- 
minogen-activating activity of re- 
ceptor-bound  uPA. HeLa  cells 
were plated at 2  x  104 cells per 
well in a 96-well tray and  incu- 
bated overnight in medium with 
5 % FBS. The next day the cul- 
tures were incubated for 45 min at 
4°C,  half of the  cultures  in 0.1 
I.tg/ml HMW-uPA in  PBS  with 
1 mg/ml  of BSA and  the  other 
half in PBS with BSA alone.  At the  indicated times,  eight con- 
trol wells and eight wells that were preincubated  with uPA were 
washed extensively with PBS/BSA; four wells in each group were 
incubated for an additional 30 min with 50 I~1 PBS containing 1 mg/ 
ml of human plasminogen, the other four incubated with PBS/BSA, 
served as background controls.  The supernatants were collected, 
centrifuged,  and their plasmin content was determined on a fibrin 
plate assay (Strickland and Beers, 1976). The results shown are the 
mean of four wells, the bars indicate standard deviation. 
To compare the invasiveness of the native HeLa cells to 
those in which the receptors were saturated with uPA,  the 
cells were inoculated onto wounded CAMs,  or CAMs re- 
sealed for 30 h.  26%  of the inoculated control HeLa cells 
were found in the mesenchyme of the wounded CAMs; the 
presence  of receptor-bound  uPA  did  not  significantly  in- 
crease this number (Fig. 10 A). In contrast, only 1.3% of the 
inoculated control HeLa cells was found in the mesenchyme 
of the  resealed  CAMs.  Binding  of uPA  to  its receptor by 
preincubation of HeLa cells with 0.2 lxg/ml of uPA increased 
their invasive ability eightfold (Fig. 10 B); higher concentra- 
tion of uPA was slightly less effective (Fig.  10 B). 
Similar results were obtained with Wish-mUK cells prein- 
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Figure 10. The effect of receptor-bound uPA on the invasiveness of 
HeLa cells. Radioactive (0.14-0.17 cpm/cell), untreated HeLa cells, 
or HeLa cells with receptor-bound  uPA (the experimental proce- 
dures used to obtain these cells were exactly as described in legend 
to Fig. 8) were inoculated (5  x  l0  s cells per CAM) on wounded 
CAMs or CAMs which, after wounding, were allowed to reseal for 
30 h.  Radioactive,  untreated  HEp3  cells  and  HEp3  cells prein- 
cubated with 0.2 Ixg/ml  ofuPA served as controls. After 20 h of in- 
cubation,  the CAMs were washed, excised, treated with trypsin- 
EDTA, and counted in a gamma counter. Each experimental point 
is the mean of results from 6 to 10 CAMs. The vertical lines rep- 
resent standard deviation. 
cubated  with  0.2  ~tg/ml  of HMW-uPA;  this  treatment in- 
creased the surface plasminogen-activating activity of these 
cells from an undetectable level to •40%  of the level found 
in HeLa cells preincubated with a  similar concentration of 
uPA (Fig. 8). In three separate experiments the average inva- 
sion rate of the control cells was 4.2% (+  1.4) of the inocu- 
lum. Binding of uPA increased the efficiency of invasion to 
14.7%  (+  3.4)  (not shown). 
As expected, preincubation of HEp3 cells, in which approxi- 
mately 90% of the receptors was occupied by endogenously 
produced  uPA  (unpublished  observations);  exogenous  en- 
zyme neither increased their plasminogen-activating activity 
(Fig.  8)  nor affected their invasive potential (Fig.  10 C). 
Discussion 
Two aspects of the results presented here deserve discussion: 
the usefulness of the CAM as a model for studying invasion 
of normal tissues by tumor cells, and the role of proteolysis, 
initiated by plasminogen activators produced by tumor cells, 
in this process. 
The search  for an universally useful model in which to 
study invasion, and particularly the invasion of connective 
tissue, has not been entirely satisfactory; in vivo studies of 
organ invasion are difficult to quantitate (Easty and Easty, 
1974;  Mareel et al.,  1975;  Noguchi et al.,  1978)  and most 
in vitro models, although simple and rapid, use acellular and 
avascular membranes that do not mimic the in vivo condi- 
tions. 
The CAM has been extensively used for serial passage of 
heterologous tumors (Harris,  1958-1959;  Karnofsky et al., 
1952; Leighton,  1964) as well as for studying some aspects 
of invasion (Armstrong et al., 1982; Ossowski, 1988; Scher 
et al., 1976).  However, the fact that in many studies the state 
of morphological integrity of the CAMs used in invasion as- 
says was not rigorously determined contributed to a diversity 
of experimental results (Poste et al., 1979; Poste and Flood, 
1979;  Scher et al.,  1976). 
We found that intentional alteration of structural integrity 
of CAMs used for tumor cell inoculation  had a  profound 
effect on their susceptibility to invasion. Even highly malig- 
nant human tumor cells (HEp3),  which were invasive and 
metastatic in the patient (Toolan,  1954),  the chick embryo 
(Harris,  1958-1959;  Ossowski and  Reich,  1980),  and the 
nude mouse (Ossowski et al., 1987) were unable to penetrate 
CAMs in which the epithelium was left intact (Figs. 3 A and 
4). In view of the fact that during the natural course of malig- 
nant dissemination the need to breach intact epithelia rarely 
exists, this may not be surprising. 
A completely different outcome was observed in wounded 
CAMs. The areas of CAMs used for tumor cell inoculation 
were mostly denuded of epithelium and,  as judged by the 
presence of hemorrhage from the underlying capillaries, this 
treatment also disrupted the basal laminae (Fig. 3, B and 6"). 
Although some difference was observed between the differ- 
ent cell lines (HEp3: metastatic [Ossowski and Reich, 1980], 
Wish and HeLa: tumorigenic [Dreano et al., 1987;  Noguchi 
et  al.,  1978]),  all  three  cell  lines  showed  relatively high 
efficiency (25-50%  of inoculum) of mesenchyme invasion 
(Figs. 1, 2, 4, 7, and 10). This very high rate of invasion sug- 
gests that, in addition to facilitation of tumor cell entry re- 
suiting from the physical damage to the CAM epithelium, 
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plasminogen which may stimulate migration or exert chemo- 
tactic effects (Lacovara et al.,  1984; McCarthy et al.,  1986; 
Morioka et al., 1987; Ossowski et al.,  1975; Valinsky et al., 
1981). 
The response of the CAM to wounding, which resulted in 
the formation of a surface layer of fibroblast-like cells and, 
most likely, extracellular matrix, (resealed CAM) provided 
a selective model in which highly malignant cells like HEp3 
were found to be more invasive than less malignant cells like 
HeLa and Wish (Figs. 7, 8, and 10, and unpublished results). 
It cannot be determined at present, however, whether the in- 
creased resistance to invasion of the resealed CAMs is the 
result of the newly formed physical barrier, the gradual reab- 
sorption of bioactive compounds released during wounding, 
or the result of the changing compositions of the inflamma- 
tory cells and their products, or a combination of the above. 
The resealed CAM allowed us to examine, in a quantitative 
way,  whether PA was  crucial for efficient invasion of the 
CAM stroma by tumor cells and, if so, which of the enzyme 
properties was indispensable for this process. We had previ- 
ously presented histological evidence indicating that the in- 
filtration of the CAM stroma by single tumor cells requires 
catalytically active uPA  (Ossowski,  1988),  an observation 
that was confirmed in the resealed CAM model. This model 
also provided an opportunity for testing whether the mere 
production of plasminogen activator by tumor cells is suffi- 
cient to endow them with invasive properties, or whether 
specific characteristics, such as the type of enzyme and its 
localization in the cell, are important determinants. 
It became evident from our results that even greatly en- 
hanced  (39-fold) tPA  activity,  achieved by  incubation  of 
HeLa cells with EGF, did not increase their invasive poten- 
tial (Fig. 7). This lack of effect could not be easily explained 
by the need of fibrin to fully express tPA activity since, even 
in the absence of fibrin,  plasminogen activation by EGF- 
stimulated cells was nearly equal to that generated by the 
highly invasive HEp3 cells (not shown).  Also, evidence of 
hemorrhage was noted in CAMs after wounding (Fig. 3 C), 
suggesting that fibrin may have been present. 
Receptors for tPA,  unlike the widely distributed uPA re- 
ceptors, have been shown to be present on endothelial cells 
(Hajjar et al.,  1987) but not on tumor cells. We found that 
preincubation of HeLa cells  with  exogenous tPA  did not 
enhance their PA activity (unpublished data).  It appeared, 
therefore, that the most likely explanation for the lack of 
effectiveness  oftPA in enhancing invasion may be its inability 
to bind to cell membranes. Additional support for this con- 
clusion was obtained through the use of human Wish-mUK 
cells,  which were stimulated to produce and secrete very 
high levelsof  mouse uPA which remained in the medium be- 
cause it could not bind to the human uPA receptors. Stimula- 
tion of mouse uPA production by these cells did not result 
in augmentation of their invasive ability. This ineffectiveness 
was not, most likely, due to the secretion of uPA in a proen- 
zyme form since the highly malignant and invasive HEp3 
cells produce exclusively pro-uPA (Wun et al.,  1982). 
In vitro conversion of chicken plasminogen to plasmin by 
human uPA, tPA, and mouse uPA in solution was found to 
be very inefficient (not shown), suggesting that, most likely, 
soluble plasmin cannot account for the observed enhance- 
ment of  tumor cell invasion. Chicken plasmin generation was 
slightly enhanced when cells (HEp3 and others) that have 
receptor bound  uPA,  were  plated  directly on  fibrin  (not 
shown). That surface-bound proteases may create more fa- 
vorable conditions for localized proteolysis has been sug- 
gested previously (Chapman et al., 1984; Plow et al., 1986; 
Stoppelli et al.,  1986). The results in this paper provide ex- 
perimental support for this notion: saturation of HeLa cell 
receptors with exogenous uPA resulted in an eightfold en- 
hancement of their invasiveness.  This effect was  not seen 
when tPA production was equally stimulated. A similar re- 
sult was noted in Wish-mUK cells: secretion of mouse uPA, 
unable to bind to the human receptors on these cells, did not 
affect their invasiveness, while a 3.5-fold enhancement of in- 
vasiveness was  observed when human uPA  was  bound to 
their surface receptors. 
The reasons for the effectiveness of the cell-bound activity 
remain to be explored; the enhancing effect of uPA may be 
due to the generation of  proteolysis in critical sites of contact 
between cells and substratum (Hebert and Baker, 1988; Ptl- 
lanen et al.,  1988), or because of increased interaction be- 
tween the enzyme and the substrate due to higher local en- 
zyme concentration  (Plow  et  al.,  1986;  Stoppelli  et  al., 
1986), or, possibly, as suggested (Campbell and Campbell, 
1988; Chapman et al.,  1984), because receptor-bound uPA 
is protected from inhibition by serum and/or cellular PA in- 
hibitors. 
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